Delta-9-Tetrahydrocannabinol (∆9-THC) & Cannabidiol (CBD) Drug-Drug Interactions
Among the remarkable initiatives to transmit the latest scientific knowledge on cannabis, and on their safety, Penn State University offers a summary of possible drug interactions with ∆9-THC or CBD. This table is updated by the university.
“Although regulatory agency approved prescribing information is often the initial source of information when identifying potential drug-drug interactions, it may only provide for a limited number of exemplars or only reference a class of medications without providing any specific medication examples. However, with the recent deregulation of CBD oil (hemp oil) and the steady increase in states and countries that have legalized recreational and medical marijuana, these products are often not associated with regulatory agency approved prescribing information.”
Reference :
Kocis P, T, Vrana K, E: Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Med Cannabis Cannabinoids 2020. doi: 10.1159/000507998
*** ndlr. : –.
Les huiles au rapport 1:2 (THC:CBD) sont dès à présent disponibles.
-
Full Spectrum HempExtract 1:2 NightBreeze™.CHF 68.00 – CHF 198.00
